Number of the records: 1  

trastuzumab emtanzín

  1. Record numberd000080044
    Date06.06.2025
    TypeM - MESH
    Topical termtrastuzumab emtanzín
    Other termEnglish (Pseudonym) Trastuzumab-DM1
    English (Pseudonym) Trastuzumab-DM1 Conjugate
    English (Pseudonym) Trastuzumab Emtansine
    Slovak (Pseudonym) Kadcyla
    Slovak (Pseudonym) ado-trastuzumab emtanzín
    Slovak (Pseudonym) trastuzumab-DM1 konjugát
    See also(Skutočné meno) imunotoxíny
    (Skutočné meno) modulátory tubulínu
    (Skutočné meno) antineoplastiká imunologické
    UDCD02.540.505.495.500D04.345.295.500.500D12.776.124.486.485.114.224.060.875.500D12.776.124.790.651.114.224.060.875.500D12.776.377.715.548.114.224.200.875.500
    NoteImmunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all